Bone metastasis: mechanisms, therapies, and biomarkers
Skeletal metastases are frequent complications of many cancers, causing bone
complications (fractures, bone pain, disability) that negatively affect the patient's quality of …
complications (fractures, bone pain, disability) that negatively affect the patient's quality of …
Targeting angiogenesis in breast cancer: current evidence and future perspectives of novel anti-angiogenic approaches
NM Ayoub, SK Jaradat, KM Al-Shami… - Frontiers in …, 2022 - frontiersin.org
Angiogenesis is a vital process for the growth and dissemination of solid cancers. Numerous
molecular pathways are known to drive angiogenic switch in cancer cells promoting the …
molecular pathways are known to drive angiogenic switch in cancer cells promoting the …
Tumor metastasis: mechanistic insights and clinical challenges
PS Steeg - Nature medicine, 2006 - nature.com
Metastatic disease is the primary cause of death for most cancer patients. Complex and
redundant pathways involving the tumor cell and the microenvironment mediate tumor …
redundant pathways involving the tumor cell and the microenvironment mediate tumor …
Mechanisms, diagnosis and treatment of bone metastases
Bone and bone marrow are among the most frequent metastatic sites of cancer. The
occurrence of bone metastasis is frequently associated with a dismal disease outcome. The …
occurrence of bone metastasis is frequently associated with a dismal disease outcome. The …
Breast cancer bone metastases: pathogenesis and therapeutic targets
N Brook, E Brook, A Dharmarajan, CR Dass… - The international journal …, 2018 - Elsevier
Breast cancer is the most common cancer affecting women worldwide, with bone
metastases presenting as the most common site of disease recurrence. Bone metastases …
metastases presenting as the most common site of disease recurrence. Bone metastases …
[HTML][HTML] Platelet-derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy
M Raica, AM Cimpean - Pharmaceuticals, 2010 - mdpi.com
Angiogenesis in normal and pathological conditions is a multi-step process governed by
positive and negative endogenous regulators. Many growth factors are involved in different …
positive and negative endogenous regulators. Many growth factors are involved in different …
Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
Introduction Studies in xenograft models and experimental models of metastasis have
implicated several β3 integrin-expressing cell populations, including endothelium, platelets …
implicated several β3 integrin-expressing cell populations, including endothelium, platelets …
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets
PP Piccaluga, C Agostinelli, A Califano… - The Journal of …, 2007 - Am Soc Clin Investig
Peripheral T cell lymphoma, unspecified (PTCL/U), the most common form of PTCL, displays
heterogeneous morphology and phenotype, poor response to treatment, and poor …
heterogeneous morphology and phenotype, poor response to treatment, and poor …
PDGF receptors as targets in tumor treatment
A Östman, CH Heldin - Advances in cancer research, 2007 - Elsevier
Signaling through platelet‐derived growth factor (PDGF) receptors contributes to multiple
tumor‐associated processes. The recent introduction of clinically useful PDGF inhibitors …
tumor‐associated processes. The recent introduction of clinically useful PDGF inhibitors …
Treatment for advanced tumors: SRC reclaims center stage
JM Summy, GE Gallick - Clinical cancer research, 2006 - AACR
Background The non–receptor protein tyrosine, Src, is a 60-kDa protein that is the
archetypal member of a nine-gene family, including Src, Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk …
archetypal member of a nine-gene family, including Src, Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk …